These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15840131)

  • 1. U.S. experience of immunomodulators in the treatment of psoriasis.
    Weller R
    Br J Dermatol; 2005 Apr; 152(4):817-8; author reply 818-9. PubMed ID: 15840131
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomodulatory drugs for psoriasis.
    Boehncke WH
    BMJ; 2003 Sep; 327(7416):634-5. PubMed ID: 14500410
    [No Abstract]   [Full Text] [Related]  

  • 3. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences.
    Kormeili T; Lowe NJ; Yamauchi PS
    Br J Dermatol; 2004 Jul; 151(1):3-15. PubMed ID: 15270867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.
    Wang TS; Tsai TF
    Acta Derm Venereol; 2014 Jan; 94(1):108-9. PubMed ID: 23624752
    [No Abstract]   [Full Text] [Related]  

  • 5. The immune system: new weapon against psoriasis.
    Johns Hopkins Med Lett Health After 50; 2006 Jul; 18(5):3, 7. PubMed ID: 16848039
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psoriasis and pregnancy : Clinical algorithm and monitoring of systemic therapy].
    Stephan B; Augustin M
    Hautarzt; 2020 Aug; 71(8):607-612. PubMed ID: 32458008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis: a fresh look.
    Galadari I; Sharif MO; Galadari H
    Clin Dermatol; 2005; 23(5):491-502. PubMed ID: 16179183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation in dermatology: lessons learned in the treatment of psoriasis.
    Charlesworth EN
    Allergy Asthma Proc; 2006; 27(2):123-5. PubMed ID: 16724630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psoriasis-associated keratitis: case report].
    Filev FS; Herbert VG; Lögering B; von Gruben V; Reich K; Klemm M
    Ophthalmologe; 2014 Dec; 111(12):1201-3. PubMed ID: 25245022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for treatment with anti-tumor necrosis factor agents in psoriasis: maintaining efficacy and safety for the long haul.
    Gordon KB; Gandhi M
    Arch Dermatol; 2010 Feb; 146(2):186-8. PubMed ID: 20157030
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.
    Griffiths CE; Strober BE; van de Kerkhof P; Ho V; Fidelus-Gort R; Yeilding N; Guzzo C; Xia Y; Zhou B; Li S; Dooley LT; Goldstein NH; Menter A;
    N Engl J Med; 2010 Jan; 362(2):118-28. PubMed ID: 20071701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis: more than cosmetic.
    Bren L
    FDA Consum; 2004; 38(5):10-6. PubMed ID: 15595142
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinician's paradigm in the treatment of psoriasis.
    Lebwohl M
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S59-69. PubMed ID: 15968265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options in the treatment of psoriasis and atopic dermatitis.
    Gottlieb AB
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S3-16. PubMed ID: 15968262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating itch in psoriasis.
    Dawn A; Yosipovitch G
    Dermatol Nurs; 2006 Jun; 18(3):227-33. PubMed ID: 16856675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis.
    Katugampola RP; Lewis VJ; Finlay AY
    Br J Dermatol; 2007 May; 156(5):945-50. PubMed ID: 17388922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ustekinumab: new drug. Suspicion of carcinogenicity: too great a risk for psoriasis patients.
    Prescrire Int; 2009 Oct; 18(103):202-4. PubMed ID: 19882785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimecrolimus--a safe and effective local immunomodulator in the treatment of inflammatory skin diseases.
    Lipozencić J
    Acta Dermatovenerol Croat; 2005; 13(1):63-9. PubMed ID: 15788149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ustekinumab: effective in a patient with severe recalcitrant generalized pustular psoriasis.
    Daudén E; Santiago-et-Sánchez-Mateos D; Sotomayor-López E; García-Díez A
    Br J Dermatol; 2010 Dec; 163(6):1346-7. PubMed ID: 20716216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.